U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135804) titled 'Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma' on July 25.
Brief Summary: This is a prospective, multicenter phase II clinical study. The subjects are patients with previously untreated locally advanced nasopharyngeal carcinoma, with clinical staging of IVA, T1-4, N3, M0. The study aims to preliminarily evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Injectionin the treatment of these patients.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Nasopharyngeal Squamous Cell Carcinoma
Intervention:
DRUG: Iparomlimab and Tuvonralimab ...